Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GW590735
Cat. No.:
0225LY-0883
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
GW590735 is an effective PPARα agonist (EC50: 4 nM) with over 500-fold selectivity over other PPAR subtypes, making it suitable for research into dyslipidemia.
Synonym:
343321-96-0; 2-methyl-2-(4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxamido)methyl)phenoxy)propanoic acid; 2-Methyl-2-(4-{[({4-Methyl-2-[4-(Trifluoromethyl)phenyl]-1,3-Thiazol-5-Yl}carbonyl)amino]methyl}phenoxy)propanoic acid; Propanoic acid, 2-methyl-2-(4-((((4-methyl-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)carbonyl)amino)methyl)phenoxy)-; 2-Methyl-2-phenoxypropanoic acid, 25a; 2-Methyl-2-{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}formamido)methyl]phenoxy}propanoic acid
CAS No.:
343321-96-0
Compound CID:
9956726
Formula:
C23H21F3N2O4S
Formula Weight:
478.48
Specification
Relative Density:
1.342 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GW590735 can be used in lipid metabolism studies as a potent and selective PPAR alpha agonist.
Library Information
Target:
PPAR
Receptor:
PPARα
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
d2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 104.5 mM
